EEG complexity as a biomarker for autism spectrum disorder risk
2011

EEG Complexity as a Biomarker for Autism Risk

Sample size: 79 publication 10 minutes Evidence: moderate

Author Information

Author(s): Williamb Bosl, Atrienne Tierney, Helen Tager-Flusberg, Charles Nelson

Primary Institution: Harvard Medical School

Hypothesis

Can modified multiscale entropy (mMSE) of resting state EEG data distinguish typically developing children from infants at high risk for autism spectrum disorder?

Conclusion

The study suggests that mMSE from resting state EEG signals may be a useful biomarker for early detection of autism risk in infants.

Supporting Evidence

  • Infants at high risk for autism showed different EEG complexity patterns compared to typically developing infants.
  • Classification accuracy for boys was close to 100% at age 9 months.
  • Significant differences in mMSE were found at most ages except 9 months.

Takeaway

This study looks at brain waves in babies to see if they can tell if a baby might have autism later on. It found that certain patterns in the brain waves can help spot babies at risk.

Methodology

The study used modified multiscale entropy (mMSE) computed from EEG data and classified infants using a multiclass support vector machine algorithm.

Potential Biases

Potential bias due to the small sample size and the reliance on EEG data from a specific age range.

Limitations

The study treated data from multiple sessions of the same infant as independent, which may not account for individual developmental trajectories.

Participant Demographics

79 infants, 46 at high risk for autism (HRA) and 33 controls, aged 6 to 24 months.

Statistical Information

P-Value

0.01

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1741-7015-9-18

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication